Evaluation of an Anti-HIV Drug Combination That Includes a Coated Form of Didanosine (ddI EC) Compared to a Typical Anti-HIV Drug Regimen

NCT00002429 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

500

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Lamivudine/Zidovudine
DRUG: Nelfinavir mesylate
DRUG: Stavudine
DRUG: Didanosine

Sponsor

Bristol-Myers Squibb